TP53 and prostate carcinoma: While the consequences of p53 deficiency are undoubtedly multiple and profound as illustrated by these findings, our study provides a simple genetic basis that helps explain the significant enrichment of TP53 mutations in prostate cancer’s progression to the CRPC stage.